Generic Amaryl (Glimepiride) Information

November 27, 2009

MRI Might Find Early Alzheimer’s

Filed under: Uncategorized — Tags: — admin @ 9:09 am

The brains of people in the very early stages of Alzheimer’s disease might become hyperactive to compensate for disease-related deterioration, a new study suggests.

Researchers from the Cleveland Clinic tested 69 mentally healthy adults, two-thirds of whom were at risk for Alzheimer’s disease because of family history or genetic markers. Functional MRI was used to monitor the participants’ brains as they were asked if they recognized the names of famous celebrities and unfamiliar people. The brain activity of at-risk people was compared with that of those not at risk for Alzheimer’s.

“Our results indicate that even though this was a relatively easy and low-effort test, there was increased activation of certain parts of the brain in at-risk individuals,” principal investigator Stephen Rao said in a news release from the clinic. “This may reflect a compensatory brain response by these participants to the earliest stages of Alzheimer’s disease.”

The findings are published in the current issue of Neurology.

Rao said that functional MRI scans might eventually be used to diagnose Alzheimer’s disease in the early stages, which could lead to improved treatment.

“Studies have shown if we can delay the onset of Alzheimer’s disease by five years, we will reduce the incidence by 50 percent,” Rao said. “If we can delay the onset by 10 years, Alzheimer’s disease will virtually be eliminated because people will have passed away for some other reason.”

November 22, 2009

High-Octane Caffeine May Trigger Headaches

Filed under: Uncategorized — admin @ 9:09 am

Caffeine, known to help alleviate headaches, may cause them if consumed in large quantities.

That’s the finding of a study of more than 50,483 people who were questioned about caffeine intake and headache frequency as part of the 1995-1997 Nord-Trondelag Health Survey (HUNT 2) in Norway.

The study was published recently in the Journal of Headache Pain.

People who drank large amounts of caffeinated beverages each day had 18 percent more non-migraine headaches than those who drank few caffeinated beverages, according to researchers at the Norwegian University of Science and Technology.

High caffeine consumption was defined as more than 500 mg of caffeine daily, about what’s in five cups of coffee. Low caffeine consumption was about 125 mg per day, the study authors noted.

But although there was “no obvious reason,” the study also found that low caffeine consumption was associated with greater odds of having chronic headaches (headaches for at least 14 days each month).

Caffeine, the world’s most commonly consumed stimulant, is a common ingredient in headache analgesics, according to information in a news release about the study from the Norwegian University of Science and Technology.

But the research on how much caffeine is optimal for headaches is conflicting. Some studies have shown that high caffeine consumption increases the prevalence of headaches and migraines, while other studies have shown no connection.

Scandinavians consume about 400 milligrams of caffeine per day on average, or about four cups of coffee. That’s about twice the average caffeine intake in the United States and elsewhere in Europe, the new release states.

It’s unclear if the caffeine is causing the headaches or if people who tend to get headaches use caffeine to treat their pain, explained lead study author Knut Hagen.

Hagen recommended that people who get frequent headaches consider cutting back on their coffee consumption.

“People who suffer from headaches should be focused on their caffeine use, because it can be a cause of their headaches,” Hagen said in the news release.

November 15, 2009

Smokers seen twice as likely to develop active TB

Filed under: Uncategorized — admin @ 9:08 am

A study in Taiwan has found that smokers are twice as likely to develop active tuberculosis compared to people who have never smoked, prompting calls for policymakers to be tougher on smoking.

The study tracked nearly 18,000 people in Taiwan representing a general population for more than three years.

“We found a two-fold increase in the risk of active TB in current smokers compared with never-smokers (those who have never smoked),” wrote the lead author Hsien-Ho Lin, a postdoctoral research fellow from Brigham and Women’s Hospital in Boston.

One in three people in the world is infected with TB but 90 percent of these will remain latent infections. The remaining 10 percent will develop active TB and fall sick at some point in their lives because of weak immune systems. For example, many people who are infected with HIV/AIDS fall sick and die from TB.

Among the 17,699 participants in the Taiwan study, 3,893 were current smokers, 552 were former smokers and 13,254 had never smoked. There were 57 new cases of active TB by the end of the three-year study.

After factoring in considerations like sex, age, living in a crowded home, household income, marital status, alcohol use and employment, the researchers still found a higher risk of active TB among current smokers.

“Based on our analysis, 17 percent of incident TB cases in this population were attributable to smoking,” they wrote.

Smokers may have reduced ability to fight intruding viruses and bacteria, such as TB, in their lungs, the experts wrote.

“When these normal defense mechanisms are compromised, the development of TB might ensue upon exposure to the TB pathogen,” they wrote in a paper published in the American Journal of Respiratory and Critical Care Medicine.

Addressing smoking would be key in any fight against TB.

“Based on results from ours and other studies, policymakers and public health personnel should consider addressing tobacco cessation as part of tuberculosis control,” Lin wrote.

TB is still a leading cause of death in the world. There were 9.3 million new cases of TB in 2007 and 1.8 million deaths.

The World Health Organization aims to bring the incidence of TB down to one case per million each year by 2050.

Dennis Yip, clinical assistant professor at the University of Hong Kong’s department of community medicine, said the study was significant given its huge sample size and monitoring over a long period — the gold standard of scientific studies.

“Previous studies have been much smaller. This is a Taiwan study but we have the same problem in China where smokers are getting younger. By the time they are 40, they would have smoked 25 years,” said Yip, who was not involved in the study.

November 10, 2009

Sabril Approved for Infantile Spasms

Filed under: Uncategorized — Tags: — admin @ 9:08 am

Sabril (vigabatrin) Oral Solution has been approved by the U.S. Food and Drug Administration to treat infantile spasms in children aged 1 month to 2 years, the agency said Friday in a news release.

Infantile spasms is characterized by severe seizures that typically start between ages 4 months and 8 months. Affected children tend to suddenly bend their bodies forward while their arms and legs stiffen. This behavior often occurs upon awakening or after the child eats, and may come in groups of up 100 spasms, the FDA said.

Underlying conditions that may give rise to the disorder include birth injury, metabolic problems and genetic abnormalities.

Sabril’s label will include the agency’s most severe “black box” warning that the drug’s use could lead to progressive loss of peripheral vision, which could be dependent on dosage and duration of use, the FDA said. The drug will only be available via a restricted distribution program, and users will be required to undergo periodic vision testing.

Sabril was approved as an orphan drug, meaning the condition it treats affects fewer than 200,000 people in the United States, the agency said.

The drug is produced by Deerfield, Ill.-based Lundbeck Inc.

Powered by WordPress